Skip to content

Study · Non-randomized trial · n = 50 · 2011

2 results

[The сomparative analysis of neyromidin and cerebrolysin effects on neurodynamic processes during craniocerebral injury].

Zhivolupov SA, Shapkova EIu, Samartsev IN, Iurin AA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2011Cited by 1 (Europe PMC)

PMID21512498 (opens in a new tab)PepBankPUB-21512498
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with mild craniocerebral injury, Cerebrolysin's beneficial impact was less apparent and valid than neyromidin's throughout the study.

    In plain wordsIn patients with mild brain injury, Cerebrolysin showed less apparent benefit than neyromidin.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseComparative neurodynamic effects
    Study

    n = 50

    Comparator
    Neyromidin with general treatment
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 ml · intravenously · 10 daysAs given in this study (human).

    Source sentences

    Summary
    Nevertheless, the impact of neyromidin was more apparent and valid throughout the whole study.
    3 context sentences
    Summary · context
    The analysis of the results suggests that the two investigated drugs have a beneficial effect on the neurodynamic disorders in case of the craniocerebral injury.
    Summary · context
    The study involved 50 patients, aged from 21 to 58 years, with mild craniocerebral injury in subacute period.
    Summary · context
    The second group of patients (n=25) received both general treatment and 10 ml of cerebrolysin intravenously 1 time a day during 10 days.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with mild craniocerebral injury, Cerebrolysin with general treatment showed a beneficial effect on neurodynamic disorders.

    In plain wordsIn patients with mild brain injury, Cerebrolysin with general treatment improved neurodynamic disorders.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseNeurodynamic disorders
    Study

    n = 25

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 ml · intravenously · 10 daysAs given in this study (human).

    Source sentences

    Summary
    The analysis of the results suggests that the two investigated drugs have a beneficial effect on the neurodynamic disorders in case of the craniocerebral injury.
    2 context sentences
    Summary · context
    The study involved 50 patients, aged from 21 to 58 years, with mild craniocerebral injury in subacute period.
    Summary · context
    The second group of patients (n=25) received both general treatment and 10 ml of cerebrolysin intravenously 1 time a day during 10 days.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.